Strōma Medical Corporation is a clinical stage medical device company formed in 2009 and located in Irvine, California. Strōma has developed, the Strōma Laser System (SLS), a patented laser technology to change eye color from brown, hazel or black to the options of a natural lighter color. This surgically non-invasive treatment requires only a topical anesthetic, is performed in a doctor’s office, requires minimal recovery time, and can be performed in less than a minute per eye per treatment. The SLS is a stand-alone technology intended to be leased to refractive surgeons worldwide (e.g., LASIK-certified ophthalmologists). Ophthalmologists with an established laser practice generally have the infrastructure necessary to market, recruit, educate, and follow-up with patients. Strōma introduces an entirely new paradigm to ophthalmology: Strōma changes how the world sees you. Strōma is well positioned to capitalize on the large unmet demand for permenant eye- color change by providing consumers with a safe and simple solution and a natural-looking result. Strōma Medical Corporation has commissioned a primary market research study through a U.S. research firm. The study concluded 17.5% of consumers with dark eyes would undergo the procedure if it were safe and effective, and an additional 35% would consider the procedure under the same conditions in the future. Combined with demographic research findings, Strōma predicts a U.S. market of approximately 850,000 individuals per year. An even greater international market opportunity exists due to larger dark-eyed populations, and a high demand for related cosmetic surgeries. Strōma anticipates a sustainable market opportunity of $2.9B worldwide at maturity. STRŌMA and Ō are registered trademarks of STRŌMA MEDICAL CORPORATION. STRŌMA® Laser System is an investigational device that is not currently approved for commercial use.